Categories: DevelopmentFutureHealthTechHumanPlatformTechnology
Osanni Bio, a development-stage therapeutics platform, is reinventing discovery and development of new medicines. We unite Biodesign-inspired innovation, technology, and capital efficiency to maximize our impact on the future of human health.
Investors 1
Mentions in press and media 6
| Date | Title | Description |
| 01.07.2026 | Osanni Bio Closes $190 Million Series B |
SAN FRANCISCO, CA, Osanni Bio, a development-stage therapeutics platform reinventing discovery and development of new medicines, announced the close of a $190 million Series B financing.
>> Click here for more funding data on Osanni ... |
| 23.06.2026 | Tetrix Raises $15M in Series A Funding | Tetrix, a NYC-based provider of an AI investment platform for limited partners in alternative markets, raised $15M in Series A funding.
The round was co-led by White Star Capital and Innovation Endeavors with participation from angel invest... |
| 23.06.2026 | Discreet biotech Osanni Bio starts making noise with $190M series B for clinical push | An under-the-radar Bay Area biotech has brought in a $190 million series B with the goal of hatching a clutch of new companies to fly its drug candidates forward.
Patient Square Capital led the fundraising round for Osanni Bio, with past su... |
| 23.06.2026 | Osanni Bio Raises $190M in Series B Funding | Osanni Bio, a San Francisco, CA-based provider of a development-stage therapeutics platform, raised $190M in Series B funding.
The round was led by Patient Square Capital with participation from the Horowitz Group, Invus Opportunities, and ... |
| 23.06.2026 | Osanni Bio Raises $190 Million In Series B Funding | Osanni Bio announced it has closed a $190 million Series B financing round led by Patient Square Capital. Existing investors Horowitz Group, Invus Opportunities, and the Retinal Degeneration Fund also participated in the round.
Osanni Bio i... |
| - | Osanni Bio | “Osanni Bio, a development-stage therapeutics platform, is reinventing discovery and development of new medicines. We unite Biodesign-inspired innovation, technology, and capital efficiency to maximize our impact on the future of human heal... |
Reviews 0
